Project Grant R43DK146600
Award Date 8/6/26
Completion Date 7/31/27
Dollars Obligated $619K
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Kscube, LLC $315,335 on August 21, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop a real-time, non-invasive urinary oxygen monitoring system for acute kidney injury prevention. The recipient will advance development of a novel continuous kidney-stress monitor for use during surgery and in intensive care units. The technology provides real-time detection of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Regents of the University of California, San Francisco $2,198,203 on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on modernizing clinical methods for assessing fluid excess removal during in-center hemodialysis treatment. The project addresses the long-standing practice of "dry weight" assessment—a trial-and-error...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Pennsylvania $792,019 on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to phenotype and predict ultrafiltration intolerance and guide transitions from continuous to intermittent kidney replacement therapy. The award funds research addressing hemodynamic complications that arise when critical-care patients transition from continuous kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Emory University $1.594 million on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a prospective longitudinal cohort study characterizing quality-of-life experiences among 221 home dialysis patients and their family caregivers. The study will examine how patients and caregivers incorporate peritoneal dialysis and home hemodialysis into daily...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Silicon Kidney LLC $354,500 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop an Intracorporeal Hemodialysis System (IHEMO) enabling home hemodialysis for end-stage kidney disease patients. Silicon Kidney LLC will develop and advance toward commercialization an implanted hemodialyzer (hemocartridge) that creates permanent vascular connections...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Panluminate Inc. $354,958 on August 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate the PAN-EXM Renal Pathology Platform, an AI-enabled diagnostic system for podocytopathies including focal segmental glomerulosclerosis, membranous nephropathy, and minimal change disease. Panluminate will deliver three core products over the 30-month period...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Minnesota Healthsolutions Corporation $628,558 on September 12, 2025, to develop and evaluate an innovative dialysis cannulation needle designed to reduce accidental needle infiltration injury during hemodialysis. The award funds work under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), which supports extramural biomedical research that improves understanding of disease...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Veterans Medical Research Foundation of San Diego $383,098 on September 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The recipient will conduct research into kidney tubule dysfunction in APOL1-associated chronic kidney disease, with focus on developing and validating tubular biomarkers that capture kidney functions—nutrient reabsorption and toxin...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Updoc AI $1.467 million on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and evaluate the UPDOC Clinical Copilot, an AI agent that directly manages medication prescriptions to improve glycemic control in type 2 diabetes mellitus. The project, titled Titration Response and Enhancement by AI Tools for T2DM (TREAT-T2DM), focuses on optimizing...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Washington University $766,951 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate imaging biomarkers for assessing high-risk deceased donor kidneys slated for transplantation. The project addresses kidney shortage by improving the accuracy of kidney quality assessment, reducing the approximately 2,500 procured kidneys discarded...